SIXTY-NINTH WORLD HEALTH ASSEMBLY Geneva, Switzerland 23–28 May 2016
A69/1 Rev.1 24 May 2016
Agenda PLENARY
1.
Opening of the Health Assembly 1.1 1.2 1.3 Appointment of the Committee on Credentials Election of the President Election of the five Vice-Presidents, the Chairmen of the main committees, and establishment of the General Committee Adoption of the agenda and allocation of items to the main committees Document A69/1
1.4
2.
Report of the Executive Board on its 137th and 138th sessions Document A69/2
3.
Address by Dr Margaret Chan, Director-General Document A69/3
4. 5. 6. 7.
Invited speaker [deleted] Executive Board: election Awards Document A69/INF./1
8. 9.
Reports of the main committees Closure of the Health Assembly
A69/1 Rev.1
COMMITTEE A 10. 11. Opening of the Committee 1 WHO reform 11.1 Overview of reform implementation Document A69/4 11.2 Member State consultative process on governance reform Documents A69/5, A69/5 Add.1 and EB138/2016/REC/1, decision EB138(1) 11.3 Framework of engagement with non-State actors Documents A69/6, A69/60 and EB138/2016/REC/1, decision EB138(3) 12. Noncommunicable diseases 12.1 Maternal, infant and young child nutrition Documents A69/7, A69/7 Add.1 and A69/7 Add.2 12.2 Report of the Commission on Ending Childhood Obesity Document A69/8 12.3 Draft global plan of action on violence Documents A69/9 and EB138/2016/REC/1, resolution EB138.R3 12.4 Prevention and control of noncommunicable diseases: responses to specific assignments in preparation for the third High-level Meeting of the United Nations General Assembly on the Prevention and Control of Non-communicable Diseases in 2018 Documents A69/10 and EB138/2016/REC/1, resolution EB138.R4 12.5 Strengthening synergies between the World Health Assembly and the Conference of the Parties to the WHO Framework Convention on Tobacco Control Documents A69/11 and A69/11 Add.1
1
Including election of Vice-Chairmen and Rapporteur.
2
A69/1 Rev.1
12.6 Public health dimension of the world drug problem including in the context of the special session of the United Nations General Assembly on the world drug problem, held in April 2016 Document A69/12 12.7 Addressing the challenges of the United Nations Decade of Action for Road Safety (2011‒2020): outcome of the second Global High-level Conference on Road Safety – Time for Results Document A69/13 13. Promoting health through the life course 13.1 Monitoring of the achievement of the health-related Millennium Development Goals Document A69/14 13.2 Health in the 2030 Agenda for Sustainable Development Documents A69/15 and EB138/2016/REC/1, resolution EB138.R5 13.3 Operational plan to take forward the Global Strategy for Women’s, Children’s and Adolescents’ Health Document A69/16 13.4 Multisectoral action for a life course approach to healthy ageing: draft global strategy and plan of action on ageing and health Document A69/17 13.5 Health and the environment: draft road map for an enhanced global response to the adverse health effects of air pollution Document A69/18 13.6 Role of the health sector in the sound management of chemicals Document A69/19 14. Preparedness, surveillance and response 14.1 Implementation of the International Health Regulations (2005) • Annual report on the implementation of the International Health Regulations (2005) Document A69/20
3
A69/1 Rev.1
• Report of the Review Committee on the Role of the International Health Regulations (2005) in the Ebola Outbreak and Response Documents A69/21, A69/21 Add.1 and A69/21 Add.2 14.2 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits Documents A69/22, A69/22 Add.1 and A69/22 Add.2 14.3 Smallpox eradication: destruction of variola virus stocks Document A69/23 14.4 Global action plan on antimicrobial resistance Documents A69/24 and A69/24 Add.1 14.5 Poliomyelitis Document A69/25 14.6 WHO response in severe, large-scale emergencies Document A69/26 14.7 Promoting the health of migrants Document A69/27 14.8 2014 Ebola virus disease outbreak • Update on 2014 Ebola virus disease outbreak and Secretariat response to other issues raised [document not issued] • Options for strengthening information-sharing on diagnostic, preventive and therapeutic products and for enhancing WHO’s capacity to facilitate access to these products, including the establishment of a global database, starting with haemorrhagic fevers Document A69/29 14.9 Reform of WHO’s work in health emergency management: WHO Health Emergencies Programme Documents A69/30 and A69/61
4
A69/1 Rev.1
15.
Communicable diseases 15.1 Draft global health sector strategies Documents A69/31, A69/32, A69/33, A69/59 and A69/59 Add.1 • HIV, 2016–2021 • Viral hepatitis, 2016–2021 • Sexually transmitted infections, 2016–2021 15.2 Global vaccine action plan Document A69/34 15.3 Mycetoma Documents A69/35 and EB138/2016/REC/1, resolution EB138.R1
COMMITTEE B 18. 19. Opening of the Committee 1 Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan Documents A69/44, A69/44 Add.1, A69/INF./4, A69/INF./5 and A69/INF./6 20. Programme budget and financial matters 20.1 WHO programmatic and financial report for 2014–2015 including audited financial statements for 2015 Documents A69/45, A69/62 and A69/INF./3 20.2 Financing of Programme budget 2016–2017 Document A69/46 • Strategic budget space allocation Documents A69/47 and EB137/2015/REC/1, decision EB137(7)
1
Including election of Vice-Chairmen and the Rapporteur.
5
A69/1 Rev.1
20.3 Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution Documents A69/48 and A69/63 20.4 [deleted] 20.5 Scale of assessments for 2017 Documents A69/49 and EB138/2016/REC/1, resolution EB138.R6 20.6 [deleted] 20.7 [deleted] 21. Audit and oversight matters 21.1 Report of the External Auditor Documents A69/50 and A69/64 21.2 Report of the Internal Auditor Documents A69/51 and A69/64 22. Staffing matters 22.1 Human resources: annual report Documents A69/52 and A69/65 22.2 Report of the International Civil Service Commission Document A69/53 22.3 Amendments to the Staff Regulations and Staff Rules Documents A69/54 and EB138/2016/REC/1, resolutions EB138.R10 and EB138.R13 22.4 Appointment of representatives of the WHO Staff Pension Committee Document A69/55
6
A69/1 Rev.1
23.
Management and legal matters 23.1 Real estate: update of the Geneva buildings renovation strategy Documents A69/56 and EB138/2016/REC/1, resolution EB138.R7 23.2 Process for the election of the Director-General of the World Health Organization Documents A69/57 and EB138/2016/REC/1, decision EB138(2)
24.
Collaboration within the United Nations system and with other intergovernmental organizations Document A69/58
16.
Health systems 16.1 Health workforce and services Documents A69/36, A69/37 and A69/37 Add.1 • Draft global strategy on human resources for health: workforce 2030 Document A69/38 • Framework on integrated people-centred health services Documents A69/39 and EB138/2016/REC/1, resolution EB138.R2 16.2 Follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination ‒ Report of the open-ended meeting of Member States Document A69/40 16.3 Substandard/spurious/falsely-labelled/falsified/counterfeit medical products Document A69/41 16.4 Addressing the global shortages of medicines, and the safety and accessibility of children’s medication Document A69/42
7
A69/1 Rev.1
17.
Progress reports Document A69/43 Communicable diseases A. Eradication of dracunculiasis (resolution WHA64.16)
Noncommunicable diseases B. Sustaining the elimination of iodine deficiency disorders (resolution WHA60.21)
Promoting health through the life course C. Strengthening of palliative care as a component of comprehensive care throughout the life course (resolution WHA67.19) Contributing to social and economic development: sustainable action across sectors to improve health and health equity [follow-up of the 8th Global Conference on Health Promotion] (resolution WHA67.12) Reproductive health: strategy to accelerate progress towards the attainment of international development goals and targets (resolution WHA57.12)
D.
E.
Health systems F. Health intervention and technology assessment in support of universal health coverage (resolution WHA67.23) Access to essential medicines (resolution WHA67.22) Access to biotherapeutic products, including similar biotherapeutic products, and ensuring their quality, safety and efficacy (resolution WHA67.21) WHO strategy on research for health (resolution WHA63.21)
G. H.
I.
Corporate services/enabling functions J. Multilingualism: implementation of action plan (resolution WHA61.12)
=
=
=
8